These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 3698351

  • 1. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A, Fujii M, Shirai D, Mikami H, Okada A, Imai E, Ando A, Orita Y, Kamada T.
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [Abstract] [Full Text] [Related]

  • 2. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ.
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [Abstract] [Full Text] [Related]

  • 3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Feb; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 4. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN, Rolton HA, Modi KS, Macdougall AI.
    Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
    [Abstract] [Full Text] [Related]

  • 5. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN, Morgan AG, Burden RP.
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [Abstract] [Full Text] [Related]

  • 6. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Jun; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

  • 7. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R, Feriani M, Mascalzoni E, Bragantini L, Ronco C, La Greca G.
    ASAIO J; 1992 Jun; 38(4):797-800. PubMed ID: 1450473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
    Tomson CR, Channon SM, Parkinson IS, Owen JP, Ward MK, Simpson JM, Laker MF.
    Nephrol Dial Transplant; 1988 Jun; 3(3):295-9. PubMed ID: 3140104
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting low values of serum albumin in CAPD patients.
    Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, Lee JH.
    Adv Perit Dial; 1996 Jun; 12():288-92. PubMed ID: 8865921
    [Abstract] [Full Text] [Related]

  • 11. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
    Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehl J.
    Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
    [Abstract] [Full Text] [Related]

  • 12. Urea kinetics evaluation of hemodialysis and CAPD patients.
    Acchiardo SR, Kraus AP, LaHatte G, Kaufman PA, Adkins D, Moore LW.
    Adv Perit Dial; 1992 Aug; 8():55-8. PubMed ID: 1361852
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxalic Acid as a uremic toxin.
    Mydlík M, Derzsiová K.
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.